×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Anebulo Pharmaceuticals Inc. (ANEB) NASDAQ

$2.34 (0.02) (-0.85%)

Market Cap: $60.49M

As of 05/16/24 10:39 AM EDT. Market open.

(ANEB)

Anebulo Pharmaceuticals Inc. (ANEB)
NASDAQ

$2.34
(0.02) (-0.85%)

Market Cap: $60.49M

As of 05/16/24 10:39 AM EDT. Market open.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR ANEBULO PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.34
Previous Close
$2.36
Days Range
$2.25 - $2.82
52 week range
$1.62 - $4.05
Volume
3,611
Avg. Volume (30 days)
6,433
Market Cap
$60.49M
Dividend Yield
-
P/E
-
Shares Outstanding
25,633,217
Open
$2.34
Previous Close
$2.36
Days Range
$2.25 - $2.82
52 week range
$1.62 - $4.05
Volume
3,611
Avg. Volume (30 days)
6,433
Market Cap
$60.49M
Dividend Yield
-
P/E
-
Shares Outstanding
25,633,217
FINANCIAL STATEMENTS FOR ANEBULO PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANEBULO PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
English Aron R.DirectorSep 28, 2022 Option Exercise$2.811,703,5774,787,0515,066,290Sep 30, 2022, 09:36 PM
English Aron R.DirectorDec 17, 2021 Buy$6.594002,6343,362,713Dec 21, 2021, 08:39 PM
English Aron R.DirectorDec 14, 2021 Buy$5.894122,4293,362,313Dec 16, 2021, 11:37 AM
English Aron R.DirectorDec 03, 2021 Buy$5.934,50026,6853,361,901Dec 03, 2021, 07:58 PM
English Aron R.DirectorDec 02, 2021 Buy$5.3013,83673,3313,357,401Dec 03, 2021, 11:16 AM
English Aron R.DirectorMay 06, 2021 Option Exercise$7.00714,2504,999,7503,343,565May 17, 2021, 09:47 PM
English Aron R.DirectorMay 06, 2021 Option Exercise$7.00714,2865,000,0023,343,601May 07, 2021, 07:23 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
English Aron R.Director09/28/20224,787,051
English Aron R.Director12/17/20212,634
English Aron R.Director12/14/20212,429
English Aron R.Director12/03/202126,685
English Aron R.Director12/02/202173,331
English Aron R.Director05/06/20214,999,750
English Aron R.Director05/06/20215,000,002
FUNDS WITH A POSITION IN ANEBULO PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC22,7770.00001%NewOther
BLACKROCK INC.4,0490%-2.32%Other
CHANGE IN SHARES OUTSTANDING FOR ANEBULO PHARMACEUTICALS INC
STOCK BUYBACKS FOR ANEBULO PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.61%
1Q
12/31/2023
06/30/2023
0.62%
2Q
12/31/2023
03/31/2023
0.61%
3Q
12/31/2023
12/31/2022
0.61%
4Q
12/31/2023
09/30/2022
10.13%
5Q
12/31/2023
06/30/2022
10.47%
6Q
12/31/2023
03/31/2022
10.47%
7Q
12/31/2023
12/31/2021
10.47%
8Q
12/31/2023
09/30/2021
10.47%
9Q
12/31/2023
06/30/2021
89.45%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.61%
1Q
06/30/2023
0.62%
2Q
03/31/2023
0.61%
3Q
12/31/2022
0.61%
4Q
09/30/2022
10.13%
5Q
06/30/2022
10.47%
6Q
03/31/2022
10.47%
7Q
12/31/2021
10.47%
8Q
09/30/2021
10.47%
9Q
06/30/2021
89.45%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ANEBULO PHARMACEUTICALS INC
LOADING...